Replies to post #401441 on Anavex Life Sciences Corp (AVXL)

[boi568]

What I have read -- not having seen the data directly -- is that Simufilam is failing to show any effect on moderate cases. And this will be a problem with Phase 3, which should have been put on hold until now to avoid mis-selecting trial participants.